ClinicalThought
View More
Axial manifestations are common in patients with PsA. How can we use the latest data on inhibition of IL-17A and IL-23 to better manage axial symptoms?
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.